A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Nammi Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Exscientia AI Limited
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Zumutor Biologics Inc.
AstraZeneca
Agenus Inc.
City of Hope Medical Center
National Cancer Institute (NCI)
Orano Med LLC
Filamon LTD
PMV Pharmaceuticals, Inc
Washington University School of Medicine
UMC Utrecht
Aveni Foundation
Monte Rosa Therapeutics, Inc
ViroMissile, Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Duke University
Washington University School of Medicine
University of Florida
AstraZeneca
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
MBrace Therapeutics
Clasp Therapeutics, Inc.
National Cancer Institute (NCI)
Centre Paul Strauss
Roswell Park Cancer Institute
Institut Bergonié
Daiichi Sankyo
NanOlogy, LLC
University of Nebraska
Oscotec Inc.
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau